Achromobacter xylosoxidans induced bronchiolitis obliterans in cystic fibrosis

Pediatric Pulmonology

Volumn 49, Issue 4, 2014, Pages 414-416

  De Baets, F ^a   Schelstraete, P ^a   Haerynck, F ^a   Van Biervliet, S ^a   De Bruyne, R ^a   Franckx, H ^b   Van Daele, S ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b Cystic Fibrosis Revalidation Centre   (Belgium)

Author keywords

A. xylosoxidans; achromobacter; bronchiolitis; bronchiolitis obliterans; cystic fibrosis; immune suppression; liver transplantation

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CIPROFLOXACIN; COTRIMOXAZOLE; FOSFOMYCIN; MEPREDNISONE; OXYGEN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE; STEROID; TACROLIMUS;

ACHROMOBACTER XYLOSOXIDANS; ACHROMOBACTER XYLOSOXIDANS INFECTION; ACUTE GRAFT REJECTION; ANASTOMOSIS; ANTIBIOTIC THERAPY; ARTICLE; ATELECTASIS; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM CULTURE; BALLOON DILATATION; BRONCHIOLITIS OBLITERANS; BRONCHOPNEUMONIA; CASE REPORT; CHILD; CHOLANGITIS; CHOLESTASIS; COMPUTER ASSISTED TOMOGRAPHY; CONVULSION; CORTICOSTEROID THERAPY; CRACKLE; CYSTIC FIBROSIS; DEVICE REMOVAL; DISEASE COURSE; DONOR; DRUG PULSE THERAPY; ENDOSCOPY; EPSTEIN BARR VIRUS; ESCHERICHIA COLI; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HISTIOCYTE; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; LIMIT OF DETECTION; LIVER FAILURE; LIVER TRANSPLANTATION; LUNG FUNCTION; LUNG LAVAGE; LYMPHOCYTE; MALE; MICROSCOPY; NOSE FEEDING; OPEN LUNG BIOPSY; POLYMERASE CHAIN REACTION; POLYMORPHONUCLEAR CELL; PORTAL HYPERTENSION; PRIORITY JOURNAL; SCHOOL CHILD; SEPTICEMIA; STEROID THERAPY; VATER PAPILLOTOMY; ACHROMOBACTER DENITRIFICANS; ADOLESCENT; COMPLICATION; GRAM NEGATIVE INFECTION; MICROBIOLOGY;

ACHROMOBACTER DENITRIFICANS; ADOLESCENT; BRONCHIOLITIS OBLITERANS; CYSTIC FIBROSIS; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MALE;

EID: 84896404093     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.22864     Document Type: Article

References (6)

1. Rønne Hansen C, Pressler T, Høiby N, Gormsen M,. Chronic infection with Achromobacter xylosoxidans in cystic fibrosis patients; a retrospective case control study. J Cyst Fibros 2006; 5: 245-251.
2. Hansen CR, Pressler T, Nielsen KG, Jensen PØ, Bjarnsholt T, Høiby N,. Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients. J Cyst Fibros 2010; 9: 51-58.
3. De Baets F, Schelstraete P, Van Daele S, Haerynck F, Vaneechoutte M,. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance. J Cyst Fibros 2007; 6: 75-78.
4. Lambiase A, Catania MR, Del Pezzo M, Rossano F, Terlizzi V, Sepe A, Raia V,. Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 2011; 30: 973-980.
5. Flume PA, Egan TM, Paradowski LJ, Detterbeck FC, Thompson JT, Yankaskas JR,. Infectious complications of lung transplantation. Impact of cystic fibrosis. Am J Respir Crit Care Med. 1994; 149: 1601-1607.
6. Fridell JA, Jain A, Reyes J, Biederman R, Green M, Sindhi R, Mazariegos GV,. Causes of mortality beyond 1 year after primary pediatric liver transplant under tacrolimus. Transplantation 2002; 74: 1721-1724.